MODD_OUT_1 [2025-04-29 08:50:18 -0400] 6174 Bytes | 1583 tokens | Cum: 1583 tkns (19.79% of 8k)
==========================================================================

Great disturbance I sense... in Modular Medical (MODD). From $0.9300 to $1.02 it climbs. The hour is 8:50 AM on Tue Apr 29, 2025. Decide we must if to ride this wave or retreat we shall.

--- COMPANY PROFILE ---
Company: Modular Medical (MODD)
IPO: IPO date unknown
Market Cap: $45,253,392
Shares Outstanding: 40,670,000
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange: XNAS
Description: Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Here’s a list of headlines for Modular Medical:

Mar-20-25 10:00AM - Modular Medical Announces $12 Million Private Placement
Feb-15-25 09:35AM - New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming
Feb-08-25 03:55PM - New to The Street Premieres Back-to-Back Episodes on Bloomberg: Episode 624 Aired Last Night, Episode 625 Airs Tonight at 6:30 PM EST as Sponsored Programming
Jan-30-25 08:00AM - Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
Jan-11-25 02:45PM - New to The Street to Air Sponsored Programming on Bloomberg Television Tonight at 6:30 PM EST Featuring HPB, PillSafe, LightPath Technologies, Modular Medical, and SGTM's Sustainable Green Team
Dec-19-24 04:01PM - Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
Dec-16-24 10:55PM - New to the Street Show #617 Airs Tonight on Fox Business at 10:30 PM PST as Sponsored Programming
Dec-03-24 08:00AM - Modular Medical Announces Conference Call to Provide Business Update
Nov-21-24 09:15PM - Modular Medical Announces Pricing of $8.2 Million Public Offering
Nov-21-24 09:15PM 04:05PM - Modular Medical Announces Proposed Public Offering
Nov-11-24 08:00AM - Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
Nov-08-24 08:00AM - Registration Is Now Open For Tribe Public's Webinar Event 'Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing' Featuring Modular Medical CEO On Monday, November 11, 2024
Nov-07-24 08:00AM - Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
Oct-31-24 03:00PM - New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKURs "Hack of the Week"
Oct-28-24 10:00AM - New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
Sep-30-24 08:00AM - Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Sep-18-24 08:00AM - Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
Sep-11-24 08:00AM - Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
Sep-09-24 08:00AM - Registration Is Now Open For Tribe Public's Webinar Event 'Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity' Featuring Modular Medical CEO On Wednesday, September 11, 2024
Sep-04-24 06:57PM - Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
Sep-04-24 06:57PM 04:35PM - Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
Aug-08-24 08:00AM - Registration is Now Open for Tribe Public's Webinar Event 'Diabetes Care Innovator Modular Medical Takes Next Steps' Featuring Modular Medical CEO on Friday, August 9, 2024

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-04-02T08:48:00Z - AI-IoT Chipset Industry Insights and Forecast 2025-2035 - Expanding Applications Across Various Sectors Coupled With Strategic Startup Funding and Continuous Technological Advancements Drive Opportunities
B2 - 2024-02-05T16:09:00Z - Modular Medical (MODD) Pairing Technology Issued New U.S. Patent
B3 - 2024-02-02T14:55:06Z - Modular Medical, Inc. (MODD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
B4 - 2023-10-31T17:36:43Z - Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B5 - 2023-10-19T12:52:14Z - Modular Medical And 2 Other Stocks Under $2 Insiders Are Buying
B6 - 2023-10-16T17:09:53Z - Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Modular Medical (MODD).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

MODD_OUT_3 [2025-04-29 08:50:19 -0400] 674 Bytes | 181 tokens | Cum: 1766 tkns (22.07% of 8k)
==========================================================================

Showing B2 (chunk 1 of 1): B2:
**Modular Medical (MODD) Pairing Technology Issued New U.S. Patent**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2221156/modular-medical-modd-pairing-technology-issued-new-us-patentModular Medical's (MODD) latest U.S. patent is likely to protect the company's technology addressing pairing and allow clinicians to easily upload and review patients' data.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_5 [2025-04-29 08:50:19 -0400] 380 Bytes | 87 tokens | Cum: 1855 tkns (23.19% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

MODD_OUT_7 [2025-04-29 08:50:20 -0400] 336 Bytes | 98 tokens | Cum: 1955 tkns (24.44% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1): A1:
Document A1 not found. Only 0 articles available.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_9 [2025-04-29 08:50:21 -0400] 529 Bytes | 138 tokens | Cum: 2095 tkns (26.19% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S10 - 2025-03-26 8-K Item 1.01 Entry into a Material Definitive Agrmt.

Private Placement

On March 20, 2025, Modular Medical, Inc. (the Company) entered into Securities Purchase Agrmts (the Purchase Agrmts) with investors (the Investors) for the private placement (the Private Placemen...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

MODD_OUT_11 [2025-04-29 08:50:21 -0400] 1182 Bytes | 291 tokens | Cum: 2388 tkns (29.85% of 8k)
==========================================================================

Showing S10 (chunk 1 of 6): S10:
Item 1.01 Entry into a Material Definitive Agreement.

Private Placement

On March 20, 2025, Modular Medical, Inc. (the Company) entered into Securities Purchase Agreements (the Purchase Agreements) with investors (the Investors) for the private placement (the Private Placement) of 6,247,656 units (each a Unit), with each Unit consisting of (A) two shares of the Companys common stock, par value $0.001 per share (Common Stock) and (B) one warrant (a Warrant) to purchase one share of Common Stock, at an offering price of $1.92 per Unit. Certain affiliates, officers and directors of the Company purchased a total of 374,478 Units in the Private Placement. The Common Stock and the Warrants included in the Units and the Common Stock underlying the Warrants are collectively referred to herein as the Securities. The Private Placement closed on March 26, 2025 with aggregate gross proceeds

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_13 [2025-04-29 08:50:22 -0400] 1182 Bytes | 251 tokens | Cum: 2641 tkns (33.01% of 8k)
==========================================================================

Showing S10 (chunk 2 of 6): totaling approximately $12 million, before deducting placement agent fees and other expenses. The Company intends to use the proceeds from the Private Placement for general corporate and working capital purposes and supply-chain optimization and margin improvement on its MODD1 product in preparation for broad commercial availability and preparing the submission to the FDA of a tubeless version of the MODD1 product, which the Company currently believes it will submit to the FDA in the third quarter of 2025, along with ongoing work to obtain the CE mark required for overseas markets.

The Warrants have an exercise price of $1.12 per share. Each Warrant is exercisable immediately and will expire four years from the date of issuance. The exercise price and number of shares of Common Stock issuable upon exercise of the warrants is subject to appropriate adjustment in the event of stock divide

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_15 [2025-04-29 08:50:23 -0400] 1182 Bytes | 264 tokens | Cum: 2907 tkns (36.34% of 8k)
==========================================================================

Showing S10 (chunk 3 of 6): nds, stock splits, reorganizations or similar events affecting the Common Stock and the exercise price. Subject to limited exceptions, an Investor may not exercise any portion of its warrants to the extent that the Investor would beneficially own more than 4.99% (or, at the election of the holder prior to the date of issuance, 9.99%) of the Companys outstanding Common Stock after exercise. In the event of certain fundamental transactions, the holder of the Warrants will have the right to receive the Black Scholes Value (as defined in the Warrants) of its Warrants calculated pursuant to a formula set forth in the Warrants, payable in cash. There is no trading market available for the Warrants on any securities exchange or nationally recognized trading system. The Company does not intend to list the Warrants on any securities exchange or nationally recognized trading system.

In addition,

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_17 [2025-04-29 08:50:23 -0400] 1182 Bytes | 256 tokens | Cum: 3165 tkns (39.56% of 8k)
==========================================================================

Showing S10 (chunk 4 of 6): pursuant to the terms of the Purchase Agreement, the officers and directors of the Company have entered into agreements providing that each such person may not, without the prior written consent of the Placement Agent (as defined below), subject to certain exceptions, offer, issue, sell, transfer or otherwise dispose of the Companys securities for a period of 60 days following the date of closing of the Private Placement. Also, pursuant to the Purchase Agreement, the Company agreed not to effect or agree to effect any Variable Rate Transaction (as defined in the Purchase Agreement) until one year after the date of closing of the Private Placement .

Newbridge Securities Corporation (the Placement Agent) acted as the Companys placement agent in connection with the Private Placement, pursuant to that certain engagement letter, dated as of February 10, 2025, between the Company and the Plac

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_19 [2025-04-29 08:50:24 -0400] 1182 Bytes | 274 tokens | Cum: 3441 tkns (43.01% of 8k)
==========================================================================

Showing S10 (chunk 5 of 6): ement Agent, pursuant to which the Company paid the Placement Agent (i) a cash fee equal to 7.25% of the aggregate gross proceeds from the sale of the Securities in the Private Placement and (ii) reimbursement for certain of out-of-pocket expenses, including for reasonable expenses and legal fees of $50,000. In addition, the Company issued to the Placement Agent or its designees warrants (the Placement Agent Warrants) to purchase up to an aggregate of 874,672 shares of Common Stock (7.0% of the Common Stock sold in the Private Placement). The Placement Agent Warrants have substantially the same terms as the Warrants except the Placement Agent Warrants will have an exercise price equal to $1.40 per share (125% of the exercise price of the Warrants). The Placement Agent Warrants will be exercisable six months from the date of issuance and expire on the fourth anniversary of the issuance da

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_21 [2025-04-29 08:50:25 -0400] 792 Bytes | 197 tokens | Cum: 3640 tkns (45.50% of 8k)
==========================================================================

Showing S10 (chunk 6 of 6): te.

Titan Partners Group, a division of American Capital Partners, acted as financial advisor to the Company and was paid a fee of $100,000.

The Securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.

Concurrent Direct Placement

Concurrently with the Private Placement, on March 20, 2025, the Com...

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

MODD_OUT_23 [2025-04-29 08:50:32 -0400] 7501 Bytes | 2077 tokens | Cum: 5719 tkns (71.49% of 8k)
==========================================================================

This is our set of metrics for Modular Medical.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+---------------------+
| Volume: 256,231 | Perf Month: -10.53% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+-----------------------+------------------------+---------------------+
| Avg Volume: 106.46K | Perf Quarter: -20.93% | Short Float: 0.57% | ROE: -257.72% |
+---------------------+-----------------------+------------------------+---------------------+
| Rel Volume: 2.50 | Index: - | Short Ratio: 1.99 | ROI: -168.85% |
+---------------------+-----------------------+------------------------+---------------------+
| RSI (14): 57.87 | Market Cap: 41.48M | Short Interest: 0.21M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+---------------------+
| ATR (14): 0.09 | Shs Outstand: 40.66M | Beta: - | EPS Surprise: 0.00% |
+---------------------+-----------------------+------------------------+---------------------+
| SMA20: 10.55% | Shs Float: 36.91M | Sales Q/Q: - | P/E: - |
+---------------------+-----------------------+------------------------+---------------------+
| SMA50: 7.68% | Inst Own: 45.01% | Sales past 5Y: 0.00% | Earnings: Feb 26 |
+---------------------+-----------------------+------------------------+---------------------+
| SMA200: -34.67% | Insider Own: 9.24% | Employees: 40 | |
+---------------------+-----------------------+------------------------+---------------------+
| Perf Week: 19.86% | Insider Trans: 34.54% | Debt/Eq: 0.09 | |
+---------------------+-----------------------+------------------------+---------------------+

The next section covers any insider trading by Modular Medical officers or majority shareholders (if available).

Inside Trans: Modular Medical, Inc. (MODD) by MANCHESTER MANAGEMENT CO LLC (Chief Executive Officer) on 2025-04-24
- Option to purchase common stock: 125000 shares at $0.94 (D)

Inside Trans: Modular Medical, Inc. (MODD) by Schmid Kevin (Chief Operating Officer) on 2025-04-24
- Option to purchase common stock: 50000 shares at $0 (D)
- Option to purchase common stock: 50000 shares at $0 (D)

Inside Trans: Modular Medical, Inc. (MODD) by DiPerna Paul (See Remarks) on 2025-04-24
- Option to purchase common stock: 200000 shares at $0 (D)
- Option to purchase common stock: 200000 shares at $0 (D)

Inside Trans: Modular Medical, Inc. (MODD) by FRANK MORGAN C. (Unknown Title) on 2025-03-31
- Option to purchase common stock: 1875 shares at $N/A (D)
- Option to purchase common stock: 7500 shares at $N/A (D)

Inside Trans: Modular Medical, Inc. (MODD) by Vos Ellen O'Connor (Unknown Title) on 2025-03-31
- Option to purchase common stock: 7500 shares at $N/A (D)

Inside Trans: Modular Medical, Inc. (MODD) by Sheibley Philip Brent (Unknown Title) on 2025-03-31
- Option to purchase common stock: 7500 shares at $N/A (D)

Inside Trans: Modular Medical, Inc. (MODD) by DeSisto Duane M (Unknown Title) on 2025-03-31
- Common stock: 2500 shares at $N/A (D)

Inside Trans: Modular Medical, Inc. (MODD) by FELSHER STEVEN G (Unknown Title) on 2025-03-31
- Common Stock: 750 shares at $1.1 (D)
- Option to purchase common stock: 7500 shares at $N/A (D)

Inside Trans: Modular Medical, Inc. (MODD) by Volkart Carmen B (Unknown Title) on 2025-03-31
- Common Stock: 625 shares at $1.1 (D)
- Option to purchase common stock: 7500 shares at $N/A (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -4804000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.02
Average Volume: 126612.9
30-Day High: 1.09
30-Day Low: 0.8

[Detailed Financials: Q3 2025]
- Total Assets: $12,149,000.00
- Total Liabilities: $1,887,000.00
- Total Equity: $10,262,000.00
- Current Assets: $7,331,000.00
- Current Liabilities: $1,383,000.00

[Income Statement: Q3 2025]
- Revenue: $0.00
- Net Income: $-4,804,000.00
- Gross Profit: N/A
- Operating Income: $-4,854,000.00
- Earnings Per Share (EPS): -0.13

[Cash Flow Statement: Q3 2025]
- Net Cash Flow: $3,093,000.00

[Detailed Financials: Q2 2025]
- Total Assets: $8,771,000.00
- Total Liabilities: $1,855,000.00
- Total Equity: $6,916,000.00
- Current Assets: $4,176,000.00
- Current Liabilities: $1,244,000.00

[Income Statement: Q2 2025]
- Revenue: $0.00
- Net Income: $-4,956,000.00
- Gross Profit: N/A
- Operating Income: $-4,996,000.00
- Earnings Per Share (EPS): -0.14

[Cash Flow Statement: Q2 2025]
- Net Cash Flow: $-1,159,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Modular Medical (MODD).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Modular Medical.

2) MARKET_SCORE[]
This conversation was initiated because MODD is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for MODD.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, MODD could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect MODD to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Modular Medical.

11) ETHICAL_RATING[]
Rate Modular Medical’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Modular Medical.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

MODD_IN_25 [2025-04-29 08:50:32 -0400] 126 Bytes | 29 tokens | Cum: 5957 tkns (74.46% of 8k)
==========================================================================

====================================
[2025-04-29 08:50:32] # Analysis Completed
Elapsed Time: 14.83 seconds